Woo GL1, Yang ML, Yin HQ, Jaffer F, Mittelman MW, Santerre JP.
J Biomed Mater Res. 2002 Jan;59(1):35-45.Biomaterial-related infections continue to represent a significant challenge to the medical community. Several approaches have been utilized to incorporate antimicrobial agents at the surface of implant devices in attempts to delay or eliminate the formation of biofilms. To date, most of these strategies have focused on drug conjugation or diffusion-limited systems for the delivery of such pharmaceutical agents. Read More